ResearcherTaipei Medical UniversityActive in the last 2 years
Tung‐Wei Hsu
Matched on OpenAlex author ID A5011597276. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 5
- Adenylosuccinate lyase in pancreatic ductal adenocarcinoma chemoresistance: from purine metabolism to metabolic vulnerability. Co-author DOI 10.20517/cdr.2026.58↗
- FOXO3a/miR-4259-driven LDHA expression as a key mechanism of gemcitabine sensitivity in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s40170-025-00377-3↗
- Nrf2-mediated adenylosuccinate lyase promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma cells through ferroptosis escape. Co-author DOI 10.1002/jcp.31416↗
- Phosphomimetic Dicer S1016E triggers a switch to glutamine metabolism in gemcitabine-resistant pancreatic cancer. Co-author DOI 10.1016/j.molmet.2022.101576↗
- ERK-mediated transcriptional activation of Dicer is involved in gemcitabine resistance of pancreatic cancer. First author DOI 10.1002/jcp.30159↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yen‐Hao Su · 5 shared papers, 2021–2026 · strength 1.04
- Paper Adenylosuccinate lyase in pancreatic ductal adenocarcinoma chemoresistance: from purine metabolism to metabolic vulnera… DOI 10.20517/cdr.2026.58↗
- Paper FOXO3a/miR-4259-driven LDHA expression as a key mechanism of gemcitabine sensitivity in pancreatic ductal adenocarcinom… DOI 10.1186/s40170-025-00377-3↗
- Paper Nrf2-mediated adenylosuccinate lyase promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma cells throu… DOI 10.1002/jcp.31416↗
- Ching‐Feng Chiu · 4 shared papers, 2021–2025 · strength 0.71
- Paper FOXO3a/miR-4259-driven LDHA expression as a key mechanism of gemcitabine sensitivity in pancreatic ductal adenocarcinom… DOI 10.1186/s40170-025-00377-3↗
- Paper Nrf2-mediated adenylosuccinate lyase promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma cells throu… DOI 10.1002/jcp.31416↗
- Paper Phosphomimetic Dicer S1016E triggers a switch to glutamine metabolism in gemcitabine-resistant pancreatic cancer. DOI 10.1016/j.molmet.2022.101576↗
- Hsin-An Chen · 1 shared paper, 2026 · strength 0.33
- Ji Min Park · 1 shared paper, 2022 · strength 0.15
- Yan‐Shen Shan · 1 shared paper, 2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.